Control Bionics Valuation
| CBL Stock | 0.07 0 1.45% |
Control Bionics seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Control Bionics from analyzing the firm fundamentals such as Current Valuation of 27.85 M, return on equity of -1.04, and Profit Margin of (0.99) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Control Bionics' price fluctuation is out of control at this time. Calculation of the real value of Control Bionics is based on 3 months time horizon. Increasing Control Bionics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Control Bionics' intrinsic value may or may not be the same as its current market price of 0.07, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.068 | Real 0.0623 | Hype 0.07 | Naive 0.0728 |
The intrinsic value of Control Bionics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Control Bionics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Control Bionics helps investors to forecast how Control stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Control Bionics more accurately as focusing exclusively on Control Bionics' fundamentals will not take into account other important factors: About Control Bionics Valuation
The stock valuation mechanism determines Control Bionics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Control Bionics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Control Bionics. We calculate exposure to Control Bionics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Control Bionics's related companies.Additional Tools for Control Stock Analysis
When running Control Bionics' price analysis, check to measure Control Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Control Bionics is operating at the current time. Most of Control Bionics' value examination focuses on studying past and present price action to predict the probability of Control Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Control Bionics' price. Additionally, you may evaluate how the addition of Control Bionics to your portfolios can decrease your overall portfolio volatility.